Fatty acid intake and the risk of dementia and cognitive decline: A review of clinical and epidemiological studies

Journal of Nutrition, Health and Aging

Volumn 4, Issue 4, 2000, Pages 202-207

  Kalmijn, S ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Aging; Elderly; Nutrition

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; FATTY ACID; OMEGA 3 FATTY ACID; SATURATED FATTY ACID;

ADULT; AGED; ATHEROSCLEROSIS; BRAIN DEVELOPMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FOOD INTAKE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEA FOOD; THROMBOSIS;

EID: 0034525836     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. A randomised controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants
2. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids
3. The effects of dietary-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats
4. Vascular risk factors for Alzheimer's disease - An epidemiologic perspective
5. Brain repair: An overview
6. Epidemiology of the dementias: Recent developments and new approaches
7. Markers of inflammation in serum and risk of dementia: The Rotterdam Study
8. A longitudinal study on diet, risk factors and cardiovascular disease in an aging cohort: The Zutphen Study
9. The incidence of dementia and intake of animal products: Preliminary findings from the Adventist Health Study
10. Dietary links to Alzheimer's disease
11. Fish consumption, cancer, and Alzheimer disease
12. Brain interleukin 1 and S-100 immunoreactivity ar eelevated in Down syndrome and Alzheimer disease
13. Effect of anti-inflammatory medications on neuropathological findings in Alzheimer's disease
14. Oxidation of low-density lipoproteins: Questions of initiation, propagation, and the effect of antioxidants
15. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans
16. Inflammation in neurodegenerative disease. Good, bad, or irrelevant?
17. Health benefits of docosahexaenoic acid (DHA)
18. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol
19. NSAIDs and incident Alzheimer's disease. The Rotterdam Study
20. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men
21. Dietary fat intake and the risk of incident dementia in the Rotterdam Study
22. Fish consumption and risk of stroke
23. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A_ 1-42 levels
24. Anti-oxidants and cognitive function: A review of clinical and epidemiological studies
25. Vascular nitric oxide may lessen Alzheimer's risk
26. Uses of ecological analysis in epidemiologic research
27. N-3 Fatty acids in the brain and retina: Evidence for their essentiality
28. Dietary intake and cognitive function in a group of elderly people
29. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam Study
30. Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people
31. Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans
32. A controlled trial of selegiline, alphatocopherol, or both as treatment for Alzheimer's disease
33. Status of risk factors for vascular dementia
34. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
35. Fatty acid compostion of brain phospholipids in aging and in Alzheimer's disease
36. High monounsaturated fatty acids intake protects against age-related cognitive decline
37. Intraneuronal beta-amyloid immunoreactivity in the CNS
38. Dietary cholesterol induces Alzheimer-like β-amyloid immunoreactivity in the rabbit brain
39. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits
40. Is amyloidogenesis during Alzheimer's disease due to an IL-I/IL-6-mediated 'acute phase response' in the brain?
41. Prevalence of dementia in older Japanese-American men in Hawaii
42. Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life